[{"Assets_0_Q2_USD":665113000.0,"CommonStockSharesOutstanding_0_Q2_shares":43883774.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-52422000.0,"NetIncomeLoss_1_Q2_USD":-27048000.0,"NetIncomeLoss_2_Q2_USD":-83597000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":43856352.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":43778720.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":43856352.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":43778720.0,"StockholdersEquity_0_Q2_USD":552932000.0,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180801"}]